ARB fails to prevent AF recurrence

26 April 2009 | by Nicola Garrett Print this article Comments Share this article
Treatment with the angiotensin receptor blocker valsartan does not reduce the incidence of recurrent atrial fibrillation, findings from the GISSI-AF trial show....

Want to read complete article? Please Sign in or Register.

Recent comments

Most viewed articles this week

Related sites